Europe Compounding Pharmacy Market Report 2019

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Compounding Pharmacy Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Pharmaceutical Ingredient Alteration (PIA) Market Performance (Volume)
  • 2.1.2 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Performance (Volume)
  • 2.1.3 Pharmaceutical Dosage Alteration (PDA) Market Performance (Volume)
  • 2.1.4 Others Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.2.1 Pharmaceutical Ingredient Alteration (PIA) Market Performance (Value)
  • 2.2.2 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Performance (Value)
  • 2.2.3 Pharmaceutical Dosage Alteration (PDA) Market Performance (Value)
  • 2.2.4 Others Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Adult Market Performance (Volume)
  • 3.1.2 Pediatric Market Performance (Volume)
  • 3.1.3 Geriatric Market Performance (Volume)
  • 3.1.4 Veterinary Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Fagron
  • 4.1.1 Fagron Profiles
  • 4.1.2 Fagron Product Information
  • 4.1.3 Fagron Compounding Pharmacy Business Performance
  • 4.1.4 Fagron Compounding Pharmacy Business Development and Market Status
• 4.2 Wedgewood Pharmacy
  • 4.2.1 Wedgewood Pharmacy Profiles
  • 4.2.2 Wedgewood Pharmacy Product Information
  • 4.2.3 Wedgewood Pharmacy Compounding Pharmacy Business Performance
  • 4.2.4 Wedgewood Pharmacy Compounding Pharmacy Business Development and Market Status
• 4.3 CAPS
  • 4.3.1 CAPS Profiles
  • 4.3.2 CAPS Product Information
  • 4.3.3 CAPS Compounding Pharmacy Business Performance
  • 4.3.4 CAPS Compounding Pharmacy Business Development and Market Status
• 4.4 FreseniusKabi
  • 4.4.1 FreseniusKabi Profiles
  • 4.4.2 FreseniusKabi Product Information
  • 4.4.3 FreseniusKabi Compounding Pharmacy Business Performance
  • 4.4.4 FreseniusKabi Compounding Pharmacy Business Development and Market Status
• 4.5 Advanced Pharma
  • 4.5.1 Advanced Pharma Profiles
  • 4.5.2 Advanced Pharma Product Information
  • 4.5.3 Advanced Pharma Compounding Pharmacy Business Performance
  • 4.5.4 Advanced Pharma Compounding Pharmacy Business Development and Market Status
• 4.6 PharMEDiumServices
  • 4.6.1 PharMEDiumServices Profiles
  • 4.6.2 PharMEDiumServices Product Information
  • 4.6.3 PharMEDiumServices Compounding Pharmacy Business Performance
  • 4.6.4 PharMEDiumServices Compounding Pharmacy Business Development and Market Status
• 4.7 Cantrell Drug
  • 4.7.1 Cantrell Drug Profiles
  • 4.7.2 Cantrell Drug Product Information
  • 4.7.3 Cantrell Drug Compounding Pharmacy Business Performance
  • 4.7.4 Cantrell Drug Compounding Pharmacy Business Development and Market Status
• 4.8 Dougherty’s Pharmacy
  • 4.8.1 Dougherty’s Pharmacy Profiles
  • 4.8.2 Dougherty’s Pharmacy Product Information
  • 4.8.3 Dougherty’s Pharmacy Compounding Pharmacy Business Performance
  • 4.8.4 Dougherty’s Pharmacy Compounding Pharmacy Business Development and Market Status
• 4.9 Institutional Pharmacy Solutions
  • 4.9.1 Institutional Pharmacy Solutions Profiles
  • 4.9.2 Institutional Pharmacy Solutions Product Information
  • 4.9.3 Institutional Pharmacy Solutions Compounding Pharmacy Business Performance
  • 4.9.4 Institutional Pharmacy Solutions Compounding Pharmacy Business Development and Market Status
• 4.10 Lorraine'sPharmacy
  • 4.10.1 Lorraine'sPharmacy Profiles
  • 4.10.2 Lorraine'sPharmacy Product Information
  • 4.10.3 Lorraine'sPharmacy Compounding Pharmacy Business Performance
  • 4.10.4 Lorraine'sPharmacy Compounding Pharmacy Business Development and Market Status
• 4.11 Triangle Compounding Pharmacy
• 4.12 Village Compounding Pharmacy
• 4.13 Olympia Pharmacy
• 4.14 B. Braun Medical
• 4.15 ITC Compounding Pharmacy
• 4.16 Pencol Compounding Pharmacy

5 Market Performance for Manufacturers

• 5.1 Europe Compounding Pharmacy Sales (K Units) and Market Share by Manufacturers 2014-2020
• 5.2 Europe Compounding Pharmacy Revenue (M USD) and Market Share by Manufacturers 2014-2020
• 5.3 Europe Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
• 5.4 Europe Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.1.2 Germany Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.1.3 Germany Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.1.4 Germany Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.2.2 UK Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.2.3 UK Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.2.4 UK Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.3.2 France Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.3.3 France Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.3.4 France Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.4.2 Russia Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.4.3 Russia Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.4.4 Russia Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.5.2 Benelux Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.5.3 Benelux Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.5.4 Benelux Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.6.2 Italy Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.6.3 Italy Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.6.4 Italy Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.7.2 Spain Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.7.3 Spain Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.7.4 Spain Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Compounding Pharmacy Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.8.2 Compounding Pharmacy Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.8.3 Compounding Pharmacy Price (USD/Unit) of Manufacturers 2014-2020
  • 6.8.4 Compounding Pharmacy Gross Margin of Manufacturers 2014-2020
  • 6.8.5 Market Concentration

7 Europe Compounding Pharmacy Market Performance (Sales Point)

• 7.1 Europe Compounding Pharmacy Sales (K Units) and Market Share by Regions 2014-2020
• 7.2 Europe Compounding Pharmacy Revenue (M USD) and Market Share by Regions 2014-2020
• 7.3 Europe Compounding Pharmacy Price (USD/Unit) by Regions 2014-2020
• 7.4 Europe Compounding Pharmacy Gross Margin by Regions 2014-2020

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.2 Germany Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.3 UK Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.4 France Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.5 Russia Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.6 Benelux Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.7 Italy Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.8 Spain Compounding Pharmacy Sales and Growth, Sales Value and Growth Rate2014-2020

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Adult Industry
• 11.2 Pediatric Industry
• 11.3 Geriatric Industry
• 11.4 Veterinary Industry

12 Market Forecast 2021-2026

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
  • 12.1.1 Europe Compounding Pharmacy Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
  • 12.1.2 Europe Compounding Pharmacy Sales (K Units) and Growth Rate 2021-2026
  • 12.1.3 Germany Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.4 UK Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.5 France Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.6 Russia Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.7 Benelux Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.8 Italy Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.9 Spain Compounding Pharmacy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
  • 12.2.1 Overall Market Performance
  • 12.2.2 Pharmaceutical Ingredient Alteration (PIA) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.3 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.4 Pharmaceutical Dosage Alteration (PDA) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.3 Sales Forecast by Application 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Adult Sales and and Growth Rate 2021-2026
  • 12.3.3 Pediatric Sales and and Growth Rate 2021-2026
  • 12.3.4 Geriatric Sales and and Growth Rate 2021-2026
  • 12.3.5 Veterinary Sales and and Growth Rate 2021-2026
• 12.4 Price (USD/Unit) and Gross Profit Forecast
  • 12.4.1 Europe Compounding Pharmacy Price (USD/Unit) Trend 2021-2026
  • 12.4.2 Europe Compounding Pharmacy Gross Profit Trend 2021-2026

13 Conclusion